DBV Technologies | DBVT - Aktiva





Aktiva Perubahan Tanggal
Acadia Pharmaceuticals USD 1.79B 51.25M 2026-09
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
Amarin USD 634.08M 9.72M 2026-09
BioCryst Pharmaceuticals USD 591.07M 33.22M 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
DBV Technologies USD 215.4M 7.8M 2026-09
Galectin Therapeutics USD 27.65M 1.76M 2024-06
Halozyme Therapeutics USD 3.47B 895.94M 2026-09
Incyte USD 7.29B 585.39M 2026-09
Insmed USD 2.23B 123.49M 2026-09
Ionis Pharmaceuticals USD 2.91B 81.91M 2026-09
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Sarepta Therapeutics USD 3.17B 22.45M 2026-09
Ultragenyx Pharmaceutical USD 1.19B 77M 2026-09
United Therapeutics USD 7.03B 186M 2026-09